July 18, 2007
Abbott 62 percent net increase on drugs
By Matthew L. Brown
Chicago-based Abbott Laboratories Inc., which has a pharmaceutical research facility in Worcester, reported a 62 percent increase in net income for the second quarter.
The company attributed the earnings jump to strong sales of its anti-inflammatory drug Humira.
Second quarter sales increased 16 percent over the same quarter a year ago to $6.37 billion.
The company's U.S. pharmaceutical division, its largest division, and the division of which the Worcester facility is part, saw sales of $3.6 billion, a 27 percent increase over the second quarter of 2006.
The company attributed the earnings jump to strong sales of its anti-inflammatory drug Humira.
Second quarter sales increased 16 percent over the same quarter a year ago to $6.37 billion.
The company's U.S. pharmaceutical division, its largest division, and the division of which the Worcester facility is part, saw sales of $3.6 billion, a 27 percent increase over the second quarter of 2006.
WBJ Web Partners
Most Recent
Most Recent
0 Comments